BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae, a leading medical genetics company ...
Add Yahoo as a preferred source to see more of our stories on Google. The logo for Labcorp is displayed on a screen on the floor of the NYSE in New York (Reuters) - Laboratory service provider Labcorp ...
Labcorp has been selected as the winning bidder in a process to acquire genetic specialist Invitae’s assets. The Burlington, NC-based company said it is acquiring the assets for $239 million in cash ...
BURLINGTON, N.C., April 24, 2024 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae rolled up several ...
Workplaces are changing, and in the case of medical genetic testing company Invitae, that meant taking 125,000 sq ft of a former outlet mall built in 1981 and transforming it into an advanced, ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has acquired from Invitae (NYSE: NVTA), a leading medical ...
– Helps to detect circulating tumor DNA (ctDNA) as a biomarker in clinical research and clinical trials for solid tumor malignancies – – May provide real-time data on therapy response, support patient ...
* CombiMatrix Corp - for services provided by Invitae, CombiMatrix Molecular Diagnostics will pay Invitae a $200 fee for each test that Invitae markets * CombiMatrix Corp - under terms of marketing ...
(Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results